Dose of doxorubicin determines severity of renal damage and responsiveness to ACE-inhibition in experimental nephrosis

Journal of Pharmacological and Toxicological Methods

Volumn 41, Issue 2-3, 1999, Pages 69-73

  Wapstra, Frits H ^a   Van Goor, Harry ^a   De Jong, Paul E ^a   Navis, Gerjan ^a   De Zeeuw, Dick ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

ACE inhibition; Adriamycin; Blood pressure; Doxorubicin; Glomerulosclerosis; Lisinopril; Nephrosis; Proteinuria

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXORUBICIN; LISINOPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; GLOMERULOSCLEROSIS; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY INJURY; MALE; NEPHROSIS; NEPHROTOXICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PROTEINURIA; RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; KIDNEY; LISINOPRIL; MALE; PROTEINURIA; RATS; RATS, WISTAR;

EID: 0032751978     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8719(99)00015-5     Document Type: Article

References (27)

1. Bertani T., Poggi A., Pozzoni R., Delaini F., Sacchi G., Thoua Y., Mecca G., Remuzzi G., Donati M.B. Adriamycin-induced nephrotic syndrome in the rat. sequence of pathologic events Lab Invest. 46:1982;16-23.
2. Bertani T., Rocchi G., Sacchi G., Mecca G., Remuzzi G. Adriamycin induced glomerulosclerosis in the rat. Am J Kidney Dis. 7:1988;12-19.
3. Beukers J.J., Hoedemaker P.J., Weening J.J. A comparison of the effects of converting enzyme inhibition and protein restriction in the experimental nephrosis. Lab Invest. 59:1988;631-640.
4. Bunag, R.D. (1984). Measurement of blood pressure in rats. In W de Jong (Ed.), Handbook of Hypertension (pp. 1-12). Amsterdam.
5. Bustos C., Gonzales E., Gonzalez-Cuadrado S., Ortiz A., Muley R., de Nicolas R., Plaza J.J., Egido J. Urinary excretion of platelet-activating factor in human and experimental nephrosis. Nephrol Dial Transplant. 11:1996;282-286.
6. de Boer E., Navis G.J., Tiebosch A.T.M., de Jong P.E., de Zeeuw D. Systemic factors are involved in the pathogenesis of proteinuria-induced glomerulosclerosis in adriamycin nephrotic rats. J Am Soc Nephrol. in press:1999.
7. Dworkin L.D., Grosser M., Feiner H.D., Ullian M., Parker M. Renal vascular effects of antihypertensive therapy in uninephrectomized SHR. Kidney Int. 35:1989;790-798.
8. Gansevoort R.T., Wapstra F.H., Weening J.J., de Jong P.E., de Zeeuw D. Sodium depletion enhances the antiproteinuric effect of ACE inhibition in established experimental nephrosis. Nephron. 60:1992;246-247.
9. Gansevoort R.T., de Zeeuw D., de Jong P.E. Long term benefits of the antiproteinuric effect of ACE inhibition in non-diabetic renal disease. Am J Kidney Dis. 2:1993;202-206.
10. Grond J., Weening J.J., van Goor H., Elema J.D. Application of puromycin aminonucleoside and adriamycin to induce chronic renal failure in the rat. Contrib Nephrol. 60:1988;83-93.
11. Hall R.L., Wilke W.L., Fettmann M.J. The progression of adriamycin-induced nephrotic syndrome in rats and the effect of captopril. Toxicol Appl Pharmacol. 82:1986;164-174.
12. Heeg J.E., de Jong P.E., van der Hem G.K., de Zeeuw D. Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril. Kidney Int. 36:1989;272-279.
13. Ikoma M., Kawamura T., Kakinuma Y., Fogo A., Ichikawa I. Cause of variable therapeutic efficacy of angiotensin converting enzyme inhibitor on glomerular lesions. Kidney Int. 40:1992;195-202.
14. Nagashima A., Okuda S., Tamaki K., Fujishima M. Influence of a high salt diet on glomerular injury and the preventive effects of amiloride in adriamycin nephropathy. Nephron. 71:1995;87-94.
15. Navis G.J., de Jong P.E., Donker A.J.M., van der Hem G.K., de Zeeuw D. Moderate sodium restriction in hypertensive subjects. renal effects of ACE inhibition Kidney Int. 31:1987;815-819.
16. Okasora T., Takikawa T., Utsunomiya Y., Senoh I., Hayashibara H., Shiraki K., Kasagi T., Shimizu F. Suppressive effect of superoxide dismutase on adriamycin nephropathy. Nephron. 60:1992;199-203.
17. Okuda S., Oh Y., Tsuruda H., Onoyama K., Fujimi S., Fujishima M. Adriamycin-induced nephropathy as a model of chronic progressive glomerular disease. Kidney Int. 29:1986;502-510.
18. Okuda S., Motomura K., Sanai T., Hirakata H., Nanishi F., Onoyama K., Fujishima M. Effect of different levels of protein intake on renal deterioration and nutritional state in experimental renal disease. Cli Sci. 73:1987;33-39.
19. Paczek L., Teschner M., Schaefer R.M., Kovar J., Romen W., Heidland A. Intraglomerular proteinase activity in adriamycin-induced nephropathy. Nephron. 60:1992;81-86.
20. Raij L., Azar S., Keane W.F. Mesangial immune injury, hypertension, and progressive glomerular damage in dahl rats. Kidney Int. 26:1984;137-141.
21. Remuzzi G., Bertani T. Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int. 38:1990;384-394. [editorial].
22. Scholey J.W., Miller P.L., Rennke H.G., Meyer T.W. Effect of converting enzyme inhibition on the course of adriamycin-induced nephropathy. Kidney Int. 36:1989;816-822.
23. Tamaki K., Okuda S., Ando T., Iwamoto T., Nakayama M., Fujishima M. TGF-beta in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathy. Kidney Int. 45:1994;525-536.
24. van Goor H., van der Horst M.L.C., Fidler V., Grond J. Glomerular macrophage modulation affects mesangial expansion in the rat after renal ablation. Lab Invest. 66:1992;564-571.
25. Wapstra F.H., van Goor H., Navis G.J., de Jong P.E., de Zeeuw D. Short term antiproteinuric effect of ACE inhibition predicts renal protection in rats with established adriamycin nephrosis. Cli Sci. 90:1996;393-400.
26. Weening J.J., Westenend P.J., Beukers J.J.B., Grond J. Experimental models of glomerulosclerosis. Contr Nephrol. 77:1990;65-76.
27. Westenend, P.J., Grond, J., & Weening, J.J. (1993). Strain and species differences in experimental models of progressive glomerulosclerosis. In N. Gretz & M. Strauch (Eds.) Basel: Karger. Experimental and Genetic Rat Models of Chronic Renal Failure. (pp. 236-249).